Pfizer COVID-19 vaccine Has green light from FDA advisory committee

The COVID-19 vaccine manufactured by Pfizer and BioNTech ought to be allowed an Emergency Use Authorization in the US Food and Drug Administration, according to a committee of independent experts guiding the bureau.

The committee–the Vaccines and Related Biological Products Advisory Committee (VRBPAC)–created the recommendation now at a vote of 17 in favour, 4 against, and one abstain. Especially they voted in the affirmative to this question:

Depending on the totality of scientific evidence available, do the advantages of this Pfizer-BioNTech COVID-19 Vaccine outweigh its dangers for use in people 16 decades old and older?

When the FDA follows the recommendation along with grants consent, the vaccine is likely to be broadly available to individuals 16 decades and older and supply of this vaccine will probably {} in the forthcoming weeks.